# Artery Flow

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/artery-flow

- Industry: Healthcare
- Headquarters: Hangzhou, China
- Website: www.arteryflow.com
- Latest round: Series A (Dec 31, 2019)
- Investors on record: 2

## About

Established in 2017 and based in Hangzhou, China, Artery Flow is a healthcare company that focuses on intelligent diagnostic of cardiovascular and cerebrovascular diseases on the basis of artificial intelligence, big data and relevant technologies. The company has established cooperation with clinicians in hundreds of hospitals to build R&D center for cardiovascular and cerebrovascular diseases. Meanwhile, the company has cooperated with Buffalo GVI in the US who is the world's top interventional treatment center. The company's core members composite with PhD and master's who graduate world-class universities, such as MIT and Imperial College.

The company provides cardiovascular and cerebrovascular disease solutions, including  intelligent screening, detection, diagnosis, and surgical planning. The company's products classified three categories, cardiovascular, cerebrovascular, and Artery Flow cloud platform. The cardiovascular includes DeepECG based on AI ECG online analysis system, AccuFFR based on non-invasive FFR analysis system for coronary CTA, DeepLV with AI automatic analysis software for left ventricular remodeling, which AccuFFR won the 2019 best innovation award in the cardiovascular field, and received conformite Europeenne (CE) certification. The cerebrovascular AneuFlow includes AneuFlow based on cerebral aneurysm auxiliary diagnosis system, and AccuStroke based on AI analysis system for ischemic stroke. The artery flow is a cloud based computing processing center.

The company plans to promote commercial application of the product for cardiovascular disease functional assessment, to expand team of sales and R&D, and to perform R&D, registration, and declaration  of new products.

## Funding rounds

- Series A, Dec 31, 2019 — Shanghai Jianyi Private Equity Fund Management
- Series A, Sep 6, 2019 — Dianshi Fund

## Investors

- Dianshi Fund (https://capitalatlas.ai/funds/dianshi-fund) — Series A
- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Series A
